Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
DEN-204
Phase 2 mab completed
Quick answer
Takeda's Tetravalent Dengue Vaccine Candidate (TDV) for Dengue Fever is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Dengue Fever
- Phase
- Phase 2
- Modality
- mab
- Status
- completed